hereditary optic neuropathy

遗传性视神经病变
  • 文章类型: Case Reports
    一名29岁女性,无家族史,表现为双侧进行性视力模糊。她的症状出现在12岁时,此后视力从双侧0.6下降到0.2,临界闪烁频率和双侧中央暗点降低。她没有相对传入的瞳孔缺损。胃镜检查显示没有明显的椎间盘充血,萎缩,或乳头周围毛细血管扩张血管。视网膜神经纤维层在每只眼睛的光学相干断层扫描上表现正常;然而,两只眼睛都观察到交叉区的丢失和中央凹的椭圆体区的破坏。多焦视网膜电图显示两个黄斑区域的振幅均降低。线粒体脱氧核糖核酸分析确定m.14502T>C突变,导致Leber遗传性视神经病变(LHON)的主要突变之一。尽管存在明显的LHON突变,然而,临床诊断为隐匿性黄斑营养不良。以前只有5例病例报告,所有这些都是零星的,其中详细介绍了m.14502T>C突变的临床特征。m.14502T>C表型与其他主要突变的表型有一定的一致性,包括年轻的发病,双侧进行性视力障碍,和典型的LHON眼底。然而,m.14502T>C单独具有极低的外显率,其表型可能是极小的或亚临床的,从我们的案例中可以看出。由于对m.14502T>C突变的临床过程知之甚少,因此LHON表型可能出现在生命的后期。此外,m.14502T>C可以作为修饰基因,这改变了其他共存的主要LHON突变的表型,包括外显率和疾病的严重程度,通过协同效应。
    A 29-year-old female with no family history presented with bilateral progressive blurred vision. Her symptoms appeared at 12-years-old and her visual acuity had since deteriorated from 0.6 to 0.2 bilaterally with decreased critical flicker frequency and bilateral central scotomas. She did not have a relative afferent pupillary defect. Fundoscopy revealed no distinct disc hyperaemia, atrophy, or peripapillary telangiectatic vessels. The retinal nerve fibre layer appeared normal on optical coherence tomography in each eye; however, loss of the interdigitation zone and the disruption of the ellipsoid zone at the fovea were observed in both eyes. Multifocal electroretinography revealed decreased amplitudes at both macula regions. Mitochondrial deoxyribonucleic acid analysis identified an m.14502T>C mutation, one of the primary mutations causing Leber\'s hereditary optic neuropathy (LHON). Despite the presence of a marked LHON mutation, however, she was clinically diagnosed as having an occult macular dystrophy. There have only been five previous case reports, all of which were sporadic, which detail the clinical characteristics of the m.14502T>C mutation. The m.14502T>C phenotype is somewhat consistent with that of the other major mutations, including young onset, bilateral progressive visual impairment, and a typical LHON fundus. Nevertheless, m.14502T>C alone has an extremely low penetrance and its phenotype may be minimal or subclinical, as seen in our case. Since little is known about the clinical course of the m.14502T>C mutation it may be possible that the LHON phenotype may appear in later stages of life. Moreover, m.14502T>C may function as a modifier gene, which alters the phenotype of other coexisting major LHON mutations, including penetrance and the severity of the disease, through synergistic effects.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号